A pilot study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE [gastro-oesophageal] junction carcinomas: Hoosier Oncology Group Study (GI05-92).
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2014
At a glance
- Drugs Cetuximab (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2008 Inclusion and exclusion criteria added as reported by ClinicalTrials.gov.